Progyny Inc
Closed
SectorHealthcare
26.6 3.78
Overview
Share price change
24h
Min
26.24
Max
26.73
Income | 12M 24M |
|---|---|
Sales | 10M 329M |
P/E Sector Avg | 33.584 49.052 |
EPS | 0.29 |
Profit margin | 7.376 |
Employees | 835 |
EBITDA | 16M 35M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +10.33% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | 477M 2B |
|---|---|
Previous open | 22.82 |
Previous close | 26.6 |
News Sentiment
By Acuity
33%
67%
82 / 342 Ranking in Healthcare
Progyny Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Progyny Inc
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.